Edition:
Deutschland

Aetna Inc (AET.N)

AET.N on New York Stock Exchange

176.81USD
18 May 2018
Change (% chg)

$-0.22 (-0.12%)
Prev Close
$177.03
Open
$177.07
Day's High
$177.56
Day's Low
$176.25
Volume
375,566
Avg. Vol
623,773
52-wk High
$194.40
52-wk Low
$139.01

AET.N

Chart for AET.N

About

Aetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health,... (more)

Buy/Sell

Sell Hold Buy
2.47 Mean rating from 17 analysts

Overall

Beta: 0.58
Market Cap(Mil.): $53,561.09
Shares Outstanding(Mil.): 332.10
Dividend: 0.50
Yield (%): 1.24
Photo

T-Mobile adds to record M&A spree

NEW YORK (LPC) - The US$38 billion (28 billion pounds) financing backing the merger of T-Mobile US and Sprint Corp is the latest high-profile M&A financing to hit the market, adding to a pipeline of deals that lenders expect will continue to grow.

Photo

T-Mobile adds to record M&A spree

NEW YORK (LPC) - The US$38bn financing backing the merger of T-Mobile US and Sprint Corp is the latest high-profile M&A financing to hit the market, adding to a pipeline of deals that lenders expect will continue to grow.

T-Mobile adds to record M&A spree

NEW YORK, May 4 (LPC) - The US$38bn financing backing the merger of T-Mobile US and Sprint Corp is the latest high-profile M&A financing to hit the market, adding to a pipeline of deals that lenders expect will continue to grow.

UPDATE 4-Humana CEO emphasizes partnerships, no clues on a major deal

May 2 The head of Humana Inc on Wednesday said the U.S. health insurer is focused on corporate partnerships and small deals to create health clinics, curbing investor hopes of an imminent major transaction as the sector undergoes a seismic consolidation.

Photo

CVS beats on higher prescription drug sales, shares up 4 percent

CVS Health Corp posted a better-than-expected first-quarter profit on Wednesday, helped by higher sales of prescription drugs at its stores, sending its shares up 4.3 percent in trading before the bell. | Video

UPDATE 2-CVS beats on higher prescription drug sales, shares up 4 pct

May 2 CVS Health Corp posted a better-than-expected first-quarter profit on Wednesday, helped by higher sales of prescription drugs at its stores, sending its shares up 4.3 percent in trading before the bell.

BRIEF-CVS Health Reports Q1 GAAP EPS $0.98 From Continuing Operations

* CVS HEALTH REPORTS FIRST QUARTER RESULTS AND CONFIRMS 2018 FULL YEAR OUTLOOK

CVS Health profit rises 4.8 pct

May 2 CVS Health Corp, which is in the process of buying health insurer Aetna Inc, reported a 4.8 percent rise in quarterly profit on Wednesday, helped by higher sales of prescription drugs at its stores.

Health insurer Humana's quarterly revenue rises about 4 pct

May 2 U.S. health insurer Humana Inc reported an about 4 percent rise first-quarter revenue on Wednesday, as it enrolled more people for its Medicare Advantage business that sells healthcare plans to the elderly and the disabled.

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.03%
Rohstoffe +0.31%
Industrie -0.07%
Konjunktur abhängige Waren & Dienstleistungen -0.44%
Konjunktur unabhängige Waren & Dienstleistungen -0.55%
Finanzindustrie +0.23%
Pharma -0.34%
Technologie -0.57%
Telekommunikation -0.07%

Nachrichten aus der Wirtschaft